Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON39453Active, not recruiting
Randomised, double-blind trial of oxycodone and fentanyl (7 arms), sponsored by Mundipharma. Primary endpoints: Dose selection for main study and Dose-response for analgesic and respiratory effects. Started Jul 2010; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON39453.